Product News

Funingpu: Pioneers in Porcine Gelatin and the Pharmaceutical Industry

Funingpu, a visionary company rooted in tradition, was founded on the principles of excellence and innovation. Since its inception, Funingpu has remained dedicated to unlocking the potential of natural resources, focusing particularly on porcine gelatin derived from the highest-quality pigs. The company’s commitment to meticulous sourcing and rigorous production standards has set it apart as a trusted name in the industry. In this essay, we will explore the diverse applications of its pharmaceutical porcine gelatin, aiming to attract more pharmaceutical manufacturers to embrace this groundbreaking ingredient.

Exploring New Horizons: Applications of Porcine Gelatin

Funingpu’s porcine gelatin has emerged as a versatile ingredient with numerous applications in the pharmaceutical industry. Primarily, this high-quality gelatin acts as a reliable excipient, facilitating the encapsulation and controlled release of active pharmaceutical ingredients. Its excellent film-forming abilities enable the production of pharmaceutical coatings, ensuring optimal drug stability and protection against environmental factors. Additionally, Funingpu’s porcine gelatin serves as a valuable component in the manufacturing of capsules, providing an efficient delivery system for oral medications. With its natural origin, outstanding biocompatibility, and extensive functionality, this gelatin proves to be an indispensable asset in enhancing pharmaceutical formulations and promoting patient well-being.


Funingpu’s rich history and commitment to excellence have positioned it as a leader in the pharmaceutical industry. Through its pioneering use of porcine gelatin, Funingpu has unlocked a realm of possibilities for drug development. As pharmaceutical manufacturers seek innovative solutions, Funingpu offers a trusted partner with unrivaled expertise in porcine gelatin applications. With Funingpu as a catalyst for innovation, pharmaceutical manufacturers can forge new pathways towards improved therapies, ultimately benefiting patients worldwide.

Related Articles

Back to top button